Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review
Daniel Gonzalez, Latika Gupta, Vijaya Murthy, et al.
Rheumatology International (2022) Vol. 42, Iss. 9, pp. 1629-1641
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C)
Paula David, Saptarshi Sinha, Khizer Iqbal, et al.
EBioMedicine (2024) Vol. 104, pp. 105136-105136
Open Access | Times Cited: 15
CAse-BAsed REview sTandards (CABARET): Considerations for Authors, Reviewers, and Editors
İlke Coşkun Benlidayı, Latika Gupta
Journal of Korean Medical Science (2024) Vol. 39
Open Access | Times Cited: 11
Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects
Е. Л. Насонов
Rheumatology Science and Practice (2024) Vol. 62, Iss. 1, pp. 32-54
Open Access | Times Cited: 7
New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review
Arvind Nune, Victor Durkowski, S. Sujitha Pillay, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1571-1571
Open Access | Times Cited: 16
The mosaic of autoimmunity – Finally discussing in person. The 13th international congress on autoimmunity 2022 (AUTO13) Athens
Naim Mahroum, Abdulrahman Elsalti, Abdulkarim Alwani, et al.
Autoimmunity Reviews (2022) Vol. 21, Iss. 10, pp. 103166-103166
Open Access | Times Cited: 20
Inflammatory myopathy following coronavirus disease 2019 vaccination: A systematic review
Yukang Ding, Yongpeng Ge
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 19
Risk factors associated with COVID‐19 pneumonia in Chinese patients with pre‐existing interstitial lung disease during the SARS‐CoV‐2 pandemic
Chi Shao, Yujie Shi, Ruxuan Chen, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 9
Open Access | Times Cited: 11
Outcome of COVID-19 in patients with idiopathic inflammatory myopathy during the Omicron wave in China: A longitudinal observational study
Ying Li, Xiaolan Tian, Chao Sun, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0317319-e0317319
Open Access
Slowly Progressive Melanoma Differentiation-Associated Gene 5 (MDA-5) Interstitial Lung Disease Following COVID-19 Infections: A Pulmonary Puzzle
S. A. Armstrong, Denise Sese, Aravind Menon
Cureus (2025)
Open Access
COVID-19 and interstitial lung diseases: A multifaceted look at the relationship between the two diseases
Jun Fukihara, Yasuhiro Kondoh
Respiratory Investigation (2023) Vol. 61, Iss. 5, pp. 601-617
Open Access | Times Cited: 10
Elderly-onset inflammatory myopathy associated with Sjögren’s syndrome following SARS-CoV-2 vaccination
Yuta Komori, Satomi Kobayashi, Keiko Hatano, et al.
Modern Rheumatology Case Reports (2024)
Closed Access | Times Cited: 2
Development of anti-MDA5 autoantibody-positive dermatomyositis following the use of etanercept biosimilar in rheumatoid arthritis
Soshi Okazaki, Tsuyoshi Shirai, Hiroko Sato, et al.
Modern Rheumatology Case Reports (2024) Vol. 8, Iss. 2, pp. 296-301
Open Access | Times Cited: 2
New-Onset MDA-5 Dermatomyositis in a Patient Following COVID-19 Vaccination: A Case Report
Eleana Bolla, G. Fragoulis, Alexios Iliopoulos
Mediterranean Journal of Rheumatology (2024) Vol. 35, Iss. 1, pp. 179-179
Open Access | Times Cited: 2
Characteristics of emerging new autoimmune diseases after COVID‐19 vaccination: A sub‐study by the COVAD group
Russka Shumnalieva, R Naveen, Jennifer Hannah, et al.
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 5
Open Access | Times Cited: 2
MDA5 Is a Major Determinant of Developing Symptoms in Critically Ill COVID-19 Patients
Amit K. Maiti
Clinical Reviews in Allergy & Immunology (2024)
Closed Access | Times Cited: 2
Increased Risk of Myositis-Specific and Myositis-Associated Autoantibodies After COVID-19 Pandemic and Vaccination: A Spanish Multicenter Collaborative Study
Laura García-Bravo, Álvaro Prada, Matías Larrañaga, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2800-2800
Open Access | Times Cited: 2
COVID-19 associated myopathy
Tom Aschman, Werner Stenzel
Current Opinion in Neurology (2022)
Closed Access | Times Cited: 9
A case of Anti‐MDA5‐Positive dermatomyositis after inactivated COVID‐19 vaccine
Lili Yang, Tinglu Ye, Huanyu Liu, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 37, Iss. 2
Open Access | Times Cited: 9
Idiopathic inflammatory myopathies linked to vaccination against SARS-CoV-2: a systematic review
Adolfo Camargo‐Coronel, H. Quiñones-Moya, M.R. Hernández-Zavala, et al.
Reumatismo (2023) Vol. 75, Iss. 1
Open Access | Times Cited: 5
Dermatomyositis in Association With SARS‐CoV‐2 Infection or COVID‐19 Vaccine
Maximiliano Diaz‐Menindez, Megan M. Sullivan, Benjamin Wang, et al.
Arthritis Care & Research (2023) Vol. 76, Iss. 1, pp. 98-104
Closed Access | Times Cited: 5
Clinical and immunological features of COVID‐19 in patients with anti‐MDA5 dermatomyositis during the omicron wave in Chongqing, China
Na Wu, Zhiwei Chen, Guanhua Zha, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Closed Access | Times Cited: 1
Association between COVID-19 Severity and Expression of Viral Nucleic Acid Sensor Genes in Peripheral Blood Mononuclear Cells and Nasopharyngeal Epithelial Cells
Zohreh‐al‐sadat Ghoreshi, Emad Behboudi, Hedyeh Askarpour, et al.
American Journal of Tropical Medicine and Hygiene (2024) Vol. 111, Iss. 2, pp. 396-402
Open Access | Times Cited: 1
Drug-Induced dermatomyositis following COVID-19 vaccination
Elliott Herron, D. Powell, Scott R. Florell, et al.
Dermatology Online Journal (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 1
Anti-MDA5 autoantibodies predict clinical dynamics of dermatomyositis following SARS-CoV-2 mRNA vaccination: a retrospective statistical analysis of case reports
C. Klein, Annkristin Heine, Peter Brossart, et al.
Rheumatology International (2024) Vol. 44, Iss. 10, pp. 2185-2196
Open Access | Times Cited: 1
Comprehensive Enteroviral Serology Links Infection and Anti‐Melanoma Differentiation‐Associated Protein 5 Dermatomyositis
Sahana Jayaraman, Eleni Tiniakou, William R. Morgenlander, et al.
ACR Open Rheumatology (2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top